373 related articles for article (PubMed ID: 28963102)
1. Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review.
Ruiz-Canela M; Hruby A; Clish CB; Liang L; Martínez-González MA; Hu FB
J Am Heart Assoc; 2017 Sep; 6(10):. PubMed ID: 28963102
[TBL] [Abstract][Full Text] [Related]
2. Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases.
Dang VT; Huang A; Werstuck GH
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):166-175. PubMed ID: 29683098
[TBL] [Abstract][Full Text] [Related]
3. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.
Shah SH; Sun JL; Stevens RD; Bain JR; Muehlbauer MJ; Pieper KS; Haynes C; Hauser ER; Kraus WE; Granger CB; Newgard CB; Califf RM; Newby LK
Am Heart J; 2012 May; 163(5):844-850.e1. PubMed ID: 22607863
[TBL] [Abstract][Full Text] [Related]
4. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.
Guasch-Ferré M; Hu FB; Ruiz-Canela M; Bulló M; Toledo E; Wang DD; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Lapetra J; Fitó M; Arós F; Serra-Majem L; Ros E; Dennis C; Liang L; Clish CB; Martínez-González MA; Salas-Salvadó J
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080862
[TBL] [Abstract][Full Text] [Related]
5. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysis.
McGranaghan P; Saxena A; Rubens M; Radenkovic J; Bach D; Schleußner L; Pieske B; Edelmann F; Trippel TD
Biomarkers; 2020 Mar; 25(2):101-111. PubMed ID: 31928240
[No Abstract] [Full Text] [Related]
7. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects.
Rizza S; Copetti M; Rossi C; Cianfarani MA; Zucchelli M; Luzi A; Pecchioli C; Porzio O; Di Cola G; Urbani A; Pellegrini F; Federici M
Atherosclerosis; 2014 Feb; 232(2):260-4. PubMed ID: 24468136
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Profile for Prediction of Ischemic Stroke in Chinese Hypertensive Population.
Guo X; Li Z; Zhou Y; Yu S; Yang H; Zheng L; Liu Y; Sun Y
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1062-1069. PubMed ID: 30642666
[TBL] [Abstract][Full Text] [Related]
9. Translating metabolomics to cardiovascular biomarkers.
Senn T; Hazen SL; Tang WH
Prog Cardiovasc Dis; 2012; 55(1):70-6. PubMed ID: 22824112
[TBL] [Abstract][Full Text] [Related]
10. [Metabolomic Profiling of Patients With Cardiovascular Diseases].
Belenkov YN; Privalova EV; Kozhevnikova MV; Korobkova EO; Ilgisonis IS; Kaplunova VY; SHakaryants GA; Appolonova SA; Kuharenko AV; Larcova EV; Mesonzhik NV
Kardiologiia; 2018 Sep; 58(9):59-62. PubMed ID: 30295200
[TBL] [Abstract][Full Text] [Related]
11. Endogenous oestradiol and cardiovascular disease in healthy men: a systematic review and meta-analysis of prospective studies.
Vandenplas G; De Bacquer D; Calders P; Fiers T; Kaufman JM; Ouwens DM; Ruige JB
Heart; 2012 Oct; 98(20):1478-82. PubMed ID: 22735686
[TBL] [Abstract][Full Text] [Related]
12. Predictive metabolites for incident myocardial infarction: a two-step meta-analysis of individual patient data from six cohorts comprising 7897 individuals from the COnsortium of METabolomics Studies.
Nogal A; Alkis T; Lee Y; Kifer D; Hu J; Murphy RA; Huang Z; Wang-Sattler R; Kastenmüler G; Linkohr B; Barrios C; Crespo M; Gieger C; Peters A; Price J; Rexrode KM; Yu B; Menni C
Cardiovasc Res; 2023 Dec; 119(17):2743-2754. PubMed ID: 37706562
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort.
Lacruz ME; Kluttig A; Tiller D; Medenwald D; Giegling I; Rujescu D; Prehn C; Adamski J; Frantz S; Greiser KH; Emeny RT; Kastenmüller G; Haerting J
Circ Cardiovasc Genet; 2016 Dec; 9(6):487-494. PubMed ID: 27784734
[TBL] [Abstract][Full Text] [Related]
14. Large-Scale Metabolomics and the Incidence of Cardiovascular Disease.
Lind L; Fall T; Ärnlöv J; Elmståhl S; Sundström J
J Am Heart Assoc; 2023 Jan; 12(2):e026885. PubMed ID: 36645074
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study.
García-Fontana B; Morales-Santana S; Díaz Navarro C; Rozas-Moreno P; Genilloud O; Vicente Pérez F; Pérez del Palacio J; Muñoz-Torres M
Talanta; 2016; 148():135-43. PubMed ID: 26653434
[TBL] [Abstract][Full Text] [Related]
16. Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort.
Huang J; Weinstein SJ; Moore SC; Derkach A; Hua X; Liao LM; Gu F; Mondul AM; Sampson JN; Albanes D
Am J Epidemiol; 2018 Aug; 187(8):1721-1732. PubMed ID: 29390044
[TBL] [Abstract][Full Text] [Related]
17. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study.
Rohrmann S; Garmo H; Malmström H; Hammar N; Jungner I; Walldius G; Van Hemelrijck M
Atherosclerosis; 2016 Aug; 251():85-93. PubMed ID: 27289190
[TBL] [Abstract][Full Text] [Related]
18. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
